HomeBlog - KDx Diagnostics

UncategorizedKDx Diagnostics And Lister Hospital Announce The Launch Of A Non-Invasive URO17® Urine Test For Bladder Cancer In The United Kingdom

December 7, 20210

Bladder CancerSBU’s Ken Shroyer shows protein serves as marker of bladder, pancreatic cancers

June 27, 2021

Bladder CancerStudy shows novel test can detect new and recurrent bladder cancer

June 4, 2021

UncategorizedKDx Diagnostics, Cardiff University, Cardiff and Vale University Health Board and Cellpath announce

June 3, 20210

UncategorizedURO17 For Detecting Bladder Cancer

February 4, 20210

Uncategorized07/03/20 KDx Diagnostics Announces CE Marking for Innovative Non-invasive URO17™ Bladder Cancer Test

July 26, 20200

Uncategorized01/08/20 KDx Diagnostics announces FDA Breakthrough Device designation for URO17™, Innovative urine

January 8, 20200

UncategorizedDemonstration of Keratin 17 Biomarker for Urothelial Carcinoma Detection

November 3, 20190

UncategorizedA Better Future

October 8, 20190

UncategorizedAcupath First Commercial Lab to Offer URO17™, Innovative New Biomarker

July 25, 20190